F-1: Wearable Devices Files for Resale of 7M Shares, Eyes $14M Cash

Wearable Devices Ltd. files an F-1 registration statement for the resale of up to 7,043,500 ordinary shares by a selling shareholder, potentially bringing in $14.1 million from warrant exercises.

Summary

• The filing registers up to 7,043,500 Ordinary Shares for resale by a selling shareholder, Armistice Capital, LLC.
• These shares are issuable upon the exercise of 1,230,000 October Warrants (exercise price $2.67 per share) and 5,813,500 November Warrants (exercise price $1.86 per share).
• The company will not receive proceeds from the sale of shares by the selling shareholder, but expects to receive up to approximately $14.1 million in cash from the exercise of these warrants.
• Wearable Devices Ltd. develops non-invasive neural input interfaces, including the Mudra Band (an Apple Watch accessory) and Mudra Link (a universal gesture control wristband).
• Revenues were $522 thousand in 2024 and $82 thousand in 2023, with comprehensive and net losses of $7.9 million and $7.8 million, respectively.
• For the six months ended June 30, 2025, revenues were $294 thousand, and comprehensive and net loss was $3.7 million.
• Over 100 companies, including 30 multinational technology companies, have purchased the Mudra Development Kit, but no licensing agreements have been signed as of February 20, 2026.
• Ordinary Shares outstanding prior to this offering were 10,211,839, with a last reported sale price of $0.795 per share on February 20, 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with cautious optimism. While the potential for $14.1 million in cash from warrant exercises is a positive for liquidity, the significant potential for shareholder dilution and the ongoing 'going concern' warning present substantial risks. The company's innovative technology and B2B customer engagement are promising, but the lack of signed licensing agreements and continued losses indicate a long path to profitability.

Positives

• The company anticipates receiving up to approximately $14.1 million in cash from the exercise of the October and November Warrants, which will be used for working capital and general corporate purposes.
• Wearable Devices is actively developing and commercializing its neural input interface technology, including B2B development kits and B2C consumer products like the Mudra Band and Mudra Link.
• Over 100 companies, including 30 multinational technology firms, have purchased the Mudra Development Kit, indicating significant industry interest in their technology.

Negatives

• Existing shareholders face significant potential dilution, as the resale involves up to 7,043,500 Ordinary Shares, representing approximately 69.0% of outstanding shares prior to the offering.
• Further potential dilution could occur from other outstanding warrants and equity incentive plans, with a scenario where outstanding shares could increase by approximately 90.2% if all September, October, and November Warrants are exercised.
• The company has a history of substantial net losses, reporting $7.9 million in 2024 and $3.7 million for the first half of 2025.
• The interim financial statements for the six months ended June 30, 2025, included an explanatory footnote regarding substantial doubt about the company's ability to continue as a going concern.
• Despite engagement with over 100 B2B customers, no licensing agreements have been signed as of February 20, 2026, with an estimated 3-5 year period from introduction to agreement.
• The company does not anticipate paying any cash dividends on its Ordinary Shares in the foreseeable future.

Risks

• Shareholders may experience significant dilution as a result of potential future financings and the exercise of existing warrants.
• The market price of Ordinary Shares could decline due to sales, or the announcements of proposed sales, of a large number of Ordinary Shares in the market, including sales by large shareholders.
• Future issuances or sales of Ordinary Shares or other equity-related securities may cause the trading price to decline and could impair the company's ability to raise capital through subsequent equity offerings.
• An active trading market for Ordinary Shares may not be sustained, which could impair investors' ability to sell shares and the company's ability to raise capital.
• The share price may be subject to substantial volatility, and shareholders may lose all or a substantial part of their investment.
• The explanatory footnote regarding substantial doubt about the company's ability to continue as a going concern could materially limit its ability to raise additional funds.
• Risks related to SNC technology becoming the industry standard input method, maintaining and expanding customer base, and device compatibility.
• Challenges in maintaining business models, correctly predicting market growth, and remediating material weaknesses in internal control over financial reporting.
• Risks concerning the ability to retain founders, maintain, protect, and enhance intellectual property, and comply with Nasdaq listing requirements.
• Impact of competition, new technologies, general market, political, and economic conditions, including geopolitical shifts and conflicts in Israel and the Middle East.
• Risks related to projected capital expenditures, liquidity, changes in strategy, and potential litigation.

Future Outlook

The company's vision is to create a world where the user's hand becomes a universal input device for touchlessly interacting with technology, believing their technology is setting the standard input interface for the Metaverse. They intend to transform interaction and control of digital devices to be as natural and intuitive as real-life experiences, imagining a future where neural-based interfaces become as ubiquitous as touchscreens for wearable computing and digital devices.

Management Comments

• Management envisions a future where the hand serves as a universal input device for touchless interaction with technology, positioning their neural-based interfaces as the standard for the Metaverse.

Industry Context

StockSavvy.ai notes that Wearable Devices Ltd. operates in the rapidly evolving neurotech and wearable technology sectors, aiming to establish a new standard for human-computer interaction, particularly relevant for augmented and virtual reality (Metaverse) applications. The company's 'push-pull' strategy with B2B development kits and B2C consumer products (Mudra Band, Mudra Link) positions it to capture market share in both enterprise and consumer segments, competing with other gesture control and brain-computer interface developers. The long sales cycle for B2B licensing agreements (3-5 years) is typical for disruptive enterprise technologies.

Comparison to Industry Standards

• The company's revenue figures ($522k in 2024, $294k in H1 2025) and significant losses ($7.9M in 2024, $3.7M in H1 2025) indicate it is still in an early commercialization phase, typical for a growth company in a nascent technology sector like neural input interfaces.
• The 3-5 year estimated period for B2B licensing agreements is a long sales cycle, which is not uncommon for complex enterprise technology integrations, but it contrasts with faster consumer product adoption cycles seen in some tech companies.
• The high dilution potential (up to 90.2% if all warrants are exercised) is a significant concern, especially when compared to more mature tech companies where dilution from warrant exercises is typically less impactful on a percentage basis.
• The 'going concern' opinion is a red flag, often seen in early-stage companies with high R&D costs and limited revenue, but it highlights a critical financial vulnerability compared to established industry players.

Corporate Governance

Related Party Transactions

• Armistice Capital, LLC, the Selling Shareholder, purchased 1,230,000 October Warrants and 5,813,500 November Warrants from the company in private placements and warrant inducement transactions.
• Prior to the offering, Armistice Capital, LLC beneficially owned 9,652,320 Ordinary Shares, representing 51.0% of the company's outstanding shares (including exercisable warrants), which would decrease to 2,608,820 shares or 13.8% if all 7,043,500 shares are sold.

Stakeholder Impact

• Shareholders will experience significant dilution if the warrants are exercised and the underlying shares are sold, potentially leading to a decline in the market price of Ordinary Shares. However, the company benefits from the cash inflow from warrant exercises.
• Employees and management are impacted by the company's ability to continue as a going concern and raise capital, which affects job security and the long-term viability of the business. Equity incentive plans are in place to align interests.
• Customers may benefit from continued research and development and commercialization efforts, supported by potential capital, which could lead to new products and improved services.
• Creditors' risk may be mitigated by the potential cash inflow from warrant exercises, which improves the company's liquidity and ability to meet its financial obligations, addressing the 'going concern' risk.

Next Steps

• The registration statement needs to become effective for the selling shareholder to sell the securities.
• The company will continue its transition from research and development to commercialization of B2B products.
• Ongoing efforts to sign licensing agreements with B2B customers are expected.
• The company aims to maintain and expand compatibility of its devices with a broad range of mobile devices and operating systems.
• Efforts to remediate material weaknesses in internal control over financial reporting are anticipated.
• The company must continue to comply with Nasdaq listing requirements.

Key Dates

Recommendation

The company operates in an innovative, high-growth sector with promising technology and B2B engagement. The potential cash infusion of $14.1 million from warrant exercises is crucial for its operations and addresses immediate liquidity concerns, which is a positive. However, the substantial dilution risk, ongoing losses, and the 'going concern' opinion present significant headwinds. A seasoned investor would likely hold to monitor progress on commercialization, particularly B2B licensing agreements, and the company's ability to achieve profitability and mitigate dilution, rather than buying into a highly speculative situation or selling before the impact of the cash infusion is fully realized.

Keywords

Wearable Devices Ltd., WLDS, SEC F-1, Registration Statement, Ordinary Shares, Warrants, Dilution, Resale, Neural Input Interface, Mudra Band, Mudra Link, Gesture Control, Wearable Technology, Neurotech, Brain-Computer Interface, Capital Raise, Nasdaq Capital Market, Armistice Capital